Cancer genetics, inc (CGIX)
Income statement / Quarterly
Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12
Revenue

2,069

1,525

6,839

17,987

535

1,281

7,667

-

8,028

6,604

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Revenue

-

-

-

-

-

-

-

-

-

-

6,966

7,230

6,750

7,001

6,068

5,484

4,001

4,185

4,370

4,035

3,221

1,511

1,430

1,854

1,705

1,831

1,218

1,075

1,242

1,148

834

Cost of revenues

960

725

4,637

12,082

685

875

5,082

5,239

4,588

4,034

4,209

4,272

4,444

4,285

4,103

4,757

3,103

3,097

3,141

3,094

2,565

1,503

1,290

1,364

1,211

1,279

1,070

1,048

971

1,085

823

Gross profit (loss)

1,109

800

2,202

5,905

-150

406

2,585

2,284

3,440

2,570

2,757

2,958

2,306

2,716

1,965

727

898

1,088

1,229

940

656

8

140

490

493

552

148

26

271

62

11

Operating expenses:
Research and development

-

7

454

-

-

16

681

1,709

981

989

1,110

1,161

1,594

1,680

1,532

1,147

1,802

1,256

1,278

1,529

1,390

1,105

596

810

433

455

490

560

501

526

523

General and administrative

1,290

1,266

3,309

10,521

1,939

1,464

5,260

8,542

4,346

3,529

3,477

4,357

3,701

3,658

4,318

5,031

3,487

3,062

2,987

4,138

3,104

2,395

2,731

1,862

1,297

1,384

1,570

1,027

1,145

1,393

936

Sales and marketing

322

322

1,108

2,971

320

386

1,591

1,553

1,301

1,165

971

937

1,054

1,379

1,298

1,726

1,243

1,184

1,116

1,226

1,070

918

748

556

442

446

396

348

334

376

339

Impairment of goodwill

2,873

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Restructuring costs

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Merger costs

284

-

249

-

890

-

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total operating expenses

4,769

1,595

5,120

18,177

3,149

1,866

7,532

11,804

6,628

5,683

5,558

6,455

6,349

6,717

7,148

7,904

6,532

5,502

5,381

6,893

5,564

4,419

4,077

3,229

2,173

2,286

2,457

1,936

1,981

2,296

1,799

Loss from continuing operations

-3,660

-795

-2,918

-12,272

-3,299

-1,460

-4,947

-9,520

-3,188

-3,113

-2,801

-3,497

-4,043

-4,001

-5,183

-7,177

-5,634

-4,414

-4,152

-5,952

-4,908

-4,411

-3,936

-2,738

-1,680

-1,733

-2,309

-1,909

-1,710

-2,233

-1,787

Other income (expense):
Interest expense

200

514

1,725

1,797

82

2

239

1,331

350

253

194

110

111

107

126

116

112

82

34

64

36

30

341

348

356

389

1,293

1,441

1,312

1,082

864

Interest income

0

0

2

-

0

0

21

-

10

10

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability

-5

-7

0

-68

13

-64

-17

-72

-105

-13

232

-33

-18

-67

-34

-360

-315

316

90

-198

0

0

0

-

-

-

-

-

-

-

-

Change in fair value of other derivatives

0

55

31

-86

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest income

-

-

-

-

-

-

-

-

-

-

17

2

4

13

4

18

5

13

13

16

18

16

22

25

3

0

0

-

-

-

-

Change in fair value of warrant liability

34

206

-7

874

12

2,154

692

1,963

2,790

577

-7,294

796

712

0

17

17

214

-181

-15

93

129

239

-44

-

-

-

5,299

1,168

3,334

1,456

1,580

Change in fair value of siParadigm Earn-Out

-982

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other expense

0

-11

-

-

-55

-23

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other expense

-

-

-

-

-

-

-

220

0

0

46

0

325

0

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Debt conversion costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-6,849

-

-

-

-

-

Change in fair value of warrant liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,033

170

-

-

-

-

-

Total other income (expense)

-1,143

-257

-1,699

-941

-138

2,193

491

510

2,555

347

-7,749

721

298

-27

-71

279

422

-566

-126

242

111

224

-362

213

-1,386

-7,408

4,005

-2,135

2,021

373

715

Loss before income taxes

-4,803

-1,052

-

-

-3,437

733

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss before income taxes

-

-

-

-

-

-

-

-9,010

-633

-2,766

-10,550

-2,776

-3,745

-4,028

-5,254

-

-

-

-

-5,709

-4,797

-4,186

-4,299

-

-

-

-

-4,044

311

-1,860

-1,072

Income (loss) before income taxes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-3,066

-9,142

1,696

-

-

-

-

Income tax benefit

0

-512

-

-

0

0

-

-1,109

0

0

-970

0

0

0

0

-

-

-

-

-536

0

0

-1,813

-0

0

0

-663

-

-

-

-

Loss from continuing operations

-4,803

-540

-

-

-3,437

733

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Discontinued Operation, Income (Loss) from Discontinued Operation, before Income Tax

6,778

-3,233

-

-

-5,082

-4,366

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net Income (Loss) Attributable to Parent

1,975

-3,773

-4,617

-3,765

-8,519

-3,633

-4,456

-7,901

-633

-2,766

-9,580

-2,776

-3,745

-4,028

-5,254

-5,714

-5,212

-4,980

-4,278

-5,173

-4,797

-4,186

-2,485

-2,524

-3,066

-9,142

2,360

-4,044

311

-1,860

-1,072

Foreign currency translation gain (loss)

-120

35

-

-

-30

85

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Basic net (loss) per share (in dollars per share)

-

-

-

-

-

-

-

-

-0.03

-0.14

-

-

-0.23

-0.28

-

-

-0.54

-

-0.44

-0.54

-0.50

-0.45

-0.27

-1.50

-0.61

-2.29

1.75

-3.01

0.23

-1.38

-0.81

Diluted net (loss) per share (in dollars per share)

-

-

-

-

-

-

-

-

-0.15

-0.16

-

-

-0.23

-0.28

-

-

-0.56

-

-0.44

-0.55

-0.51

-0.47

-0.27

1.44

-0.61

-2.29

-2.18

-4.15

-2.23

-2.32

-1.85

Basic weighted-average shares outstanding (in shares)

-

-

-

-

-

-

-

-

21,577

19,697

-

-

16,519

14,538

-

-

9,726

-

9,704

9,640

9,575

9,302

9,276

8,268

5,055

3,985

1,349

1,347

1,346

1,346

1,329

Diluted weighted-average shares outstanding (in shares)

-

-

-

-

-

-

-

-

22,359

20,663

-

-

16,519

14,538

-

-

9,728

-

9,704

9,676

9,575

9,318

9,276

8,312

5,055

3,985

1,349

1,166

1,355

1,429

1,433

Foreign currency translation (loss)

-

-

-76

-

-

-

-20

-

-1

0

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Comprehensive income (loss)

1,855

-3,738

-4,693

-3,809

-8,549

-3,548

-4,476

-7,831

-634

-2,766

-9,580

-

-3,745

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Basic and diluted net loss per share from continuing operations (usd per share)

-2.38

-0.01

-

-

-3.77

0.03

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Basic and diluted net income (loss) per share from discontinuing operations (usd per share)

3.36

-0.06

-

-

-5.57

-0.16

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Basic and diluted net income (loss) per share (usd per share)

0.98

-0.07

-0.09

8.88

-9.34

-0.13

-0.16

-

-

-

-0.51

-

-

-

-0.39

-

-

-0.51

-

-

-

-

-

-

-

-

-

-

-

-

-

Basic and diluted weighted-average shares outstanding

2,014

57,164

48,933

54,154

912

27,049

27,049

-

-

-

18,904

-

-

-

13,547

-

-

9,715

-

-

-

-

-

-

-

-

-

-

-

-

-